You are here

R&D

Merck, Lilly launch manufacturing R&D consortium to help ‘bolster’ U.S. production

Pharma Voice

Wed, 02/19/25 - 09:44 am

drug manufacturing

Young Institute Pharmaceutical Manufacturing Consortium

Biogen pays Stoke $165M, bagging Dravet prospect to fire up late-phase pipeline

Fierce Biotech

Tue, 02/18/25 - 11:12 am

Stoke Therapeutics

Dravet syndrome

Merck Is Embracing AI, But ‘We Always Have a Human in the Loop,’ Exec Says

MedCity News

Tue, 02/18/25 - 09:43 am

artificial intelligence

GSK plans to move vaccine R&D center from Rockville, Maryland, to the Boston area

Fierce Biotech

Wed, 02/12/25 - 09:33 am

Scientists Warn Trump's Medical Research Cuts Endanger Patients as Judge Blocks the Move for Now

US News and World Report

Tue, 02/11/25 - 11:13 am

NIH caps 'indirect costs' in biomedical research grants, aims to save $4B per year

Fierce Biotech

Mon, 02/10/25 - 11:56 am

X4 lays off 30% of staff, halts preclinical R&D to focus on Xolremdi rollout

Fierce Biotech

Thu, 02/6/25 - 11:45 am

X4 Pharmaceuticals

As financial headwinds pick up, pharmas are aiming to squeeze more ROI from their R&D

Pharma Voice

Wed, 02/5/25 - 11:20 am

drug development

Is federal funding frozen? Has it already thawed? Flip-flop leaves biopharma on edge

Pharma Voice

Fri, 01/31/25 - 11:10 am

federal funding

J&J is all in on tau-targeted Alzheimer’s candidates. Will the approach lead to more effective treatments?

Pharma Voice

Fri, 01/24/25 - 11:32 am

Alzheimer's disease

Biogen research team hit by layoffs as company shifts resources to external opportunities

Fierce Biotech

Wed, 01/22/25 - 07:29 pm

Bavarian Nordic plans to shut down San Diego R&D site, lay off 48 employees

Fierce Biotech

Wed, 12/11/24 - 10:51 pm

Bavarian Nordic

Pfizer, under pressure to change, names oncology head as new R&D chief

BioPharma Dive

Wed, 11/20/24 - 11:33 am

23andMe, Mirador enter strategic research collaboration

Tip Ranks

Wed, 11/20/24 - 11:28 am

precision medicine

What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine

Pharma Voice

Tue, 11/19/24 - 10:57 am

CSL Behring shuts down California cell and gene therapy R&D site amid group pivot

Fierce Biotech

Mon, 11/18/24 - 11:27 am

Life science firms move ahead on AI, with concerns

Axios

Fri, 11/15/24 - 11:07 am

artificial intelligence

drug manufacturing

Gilead lays off 72 workers in Seattle, plans to shutter R&D support site

Fierce Biotech

Thu, 11/14/24 - 11:08 pm

Gilead Sciences

Pharma’s grip on cancer R&D is having unintended consequences

Pharma Voice

Wed, 11/13/24 - 10:52 am

Novartis pays Schrödinger $150M, bets billions on the back end to form drug discovery pact

Fierce Biotech

Tue, 11/12/24 - 11:02 am

Pages